FDA grants fast-track status to Innocoll's surgical implant

11/19/2008 | Pharmaceutical Business Review Online

The FDA has given fast-track designation to Innocoll's Gentamicin, a biodegradable surgical implant. The device is being tested in two late-stage studies as a supplement to systemic antibiotic treatment aimed at preventing surgical-site infections among high-risk patients.

View Full Article in:

Pharmaceutical Business Review Online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA